Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Thrombophilia and adverse pregnancy outcome.Obstet Gynecol Clin North Am. 2006; 33 (ix): 443-456
- ACOG educational bulletin. Thromboembolism in pregnancy. Number 234, March 1997. American College of Obstetricians and Gynecologists.Int J Gynaecol Obstet. 1997; 57: 209-218
- Creasy and Resnik's maternal-fetal medicine: principles and practice.6th edition. Saunders/Elsevier, Philadelphia2009
- Hemostasis during normal pregnancy and puerperium.Semin Thromb Hemost. 2003; 29: 125-130
- Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Investigation and management of heritable thrombophilia.Br J Haematol. 2001; 114: 512-528
- Venous thromboembolic disease and pregnancy.N Engl J Med. 2008; 359: 2025-2033
- Thrombosis in pregnancy: maternal and fetal issues.Lancet. 1999; 353: 1258-1265
- Venous thrombosis: a multicausal disease.Lancet. 1999; 353: 1167-1173
- Inherited thrombophilias in pregnant patients: detection and treatment paradigm.Obstet Gynecol. 2002; 99: 333-341
- Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.N Engl J Med. 2000; 342: 374-380
- A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.Blood. 1996; 88: 3698-3703
- Incidence and diagnosis of deep vein thrombosis associated with pregnancy.Acta Obstet Gynecol Scand. 1983; 62: 239-243
- Inherited thrombophilia and pregnancy.Curr Opin Obstet Gynecol. 1998; 10: 135-144
- Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.Thromb Haemost. 1997; 77: 197-211
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.Nat Genet. 1995; 10: 111-113
- Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677 T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.Blood Coagul Fibrinolysis. 2002; 13: 271-275
- Absence of thrombosis in subjects with heterozygous protein C deficiency.N Engl J Med. 1987; 317: 991-996
- Prevalence of protein C deficiency in the healthy population.Thromb Haemost. 1995; 73: 87-93
- The nucleotide sequence of the gene for human protein C.Proc Natl Acad Sci U S A. 1985; 82: 4673-4677
- Evolution and organization of the human protein C gene.Proc Natl Acad Sci U S A. 1986; 83: 546-550
- The regulation of hemostasis: the protein C system.N Engl J Med. 1986; 314: 1298-1304
- A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state.Br J Haematol. 2001; 113: 636-641
- Two genes homologous with human protein S cDNA are located on chromosome 3.Thromb Haemost. 1987; 58: 982-987
- Organization of the human protein S genes.Biochemistry. 1990; 29: 7845-7852
- The protein C anticoagulant pathway.Arterioscler Thromb. 1992; 12: 135-145
- Plasma protein S deficiency in familial thrombotic disease.Blood. 1984; 64: 1297-1300
- Hereditary protein S deficiency and venous thrombo-embolism. A study in three Dutch families.Thromb Haemost. 1985; 53: 273-277
- Characterization of a large chromosomal deletion in the PROS1 gene of a patient with protein S deficiency type I using long PCR.Br J Haematol. 1996; 92: 986-991
- Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.Blood. 1995; 85: 3518-3523
- Associations of protein C and protein S with serum lipid concentrations.Br J Haematol. 1998; 102: 609-615
- ACOG Practice Bulletin #68: antiphospholipid syndrome.Obstet Gynecol. 2005; 106: 1113-1121
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).J Thromb Haemost. 2006; 4: 295-306
- Laboratory tests for the Antiphospholipid syndrome: current concepts.Pathology. 2004; 36: 129-138
- Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” autoantibodies.Blood. 1994; 84: 2854-2867
- Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.Ann Intern Med. 2005; 143: 697-706
- Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.Am J Obstet Gynecol. 2006; 194: 1311-1315
- Antiphospholipid syndrome review.Clin Lab Med. 2009; 29: 305-319
- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Arthritis Rheum. 2002; 46: 1019-1027
- Clinical consequences of antiphospholipid antibodies: an historic cohort study.Obstet Gynecol. 1994; 83: 372-377
- Inherited thrombophilia and gestational venous thromboembolism.Best Pract Res Clin Haematol. 2003; 16: 243-259
- Genetic susceptibility to venous thrombosis.N Engl J Med. 2001; 344: 1222-1231
- Thrombophilia in pregnancy: a systematic review.Br J Haematol. 2006; 132: 171-196
- Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.Am J Hum Genet. 1988; 43: 414-421
- Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.J Thromb Haemost. 2005; 3: 292-299
- Prothrombin 20210 G–>A, MTHFR C677 T mutations in women with venous thromboembolism associated with pregnancy.BJOG. 2000; 107: 565-569
- Mutations C677 T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.Blood Coagul Fibrinolysis. 2002; 13: 423-431
- Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial.Blood. 2007; 109: 139-144
- Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.Ann Intern Med. 1996; 125: 955-960
- Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects.Thromb Haemost. 1994; 72: 209-213
- Antiphospholipid antibodies and fetal death.Obstet Gynecol. 1996; 87: 489-493
- Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).BMJ. 1997; 314: 253-257
- Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.Am J Obstet Gynecol. 1996; 174: 1584-1589
- Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.Obstet Gynecol. 2002; 100: 408-413
- How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.Eur J Obstet Gynecol Reprod Biol. 2002; 101: 6-14
- Thrombophilic disorders and fetal loss: a meta-analysis.Lancet. 2003; 361: 901-908
- Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis.Arch Intern Med. 2004; 164: 558-563
- Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control ‘NOHA first’ study.J Thromb Haemost. 2005; 3: 2178-2184
- Maternal thrombophilias are not associated with early pregnancy loss.Thromb Haemost. 2004; 91: 290-295
- Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.Blood. 2004; 103: 3695-3699
- Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.Obstet Gynecol. 1992; 80: 614-620
- A study of sixty pregnancies in patients with the antiphospholipid syndrome.Clin Exp Rheumatol. 1996; 14: 131-136
- Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy.Obstet Gynecol. 1995; 86: 555-559
- Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study.Ann Intern Med. 1994; 120: 470-475
- Antiphospholipid antibodies in pregnancy: prevalence and clinical associations.Br J Obstet Gynaecol. 1993; 100: 909-913
- Genetic thrombophilias and intrauterine growth restriction: a meta-analysis.Obstet Gynecol. 2009; 113: 1206-1216
- ACOG Practice Bulletin No. 102: Management of stillbirth.Obstet Gynecol. 2009; 113: 748-761
- Prevention and management of venous thromboembolism in pregnancy.Am J Med. 2007; 120: S26-S34
- Heparin therapy during pregnancy. Risks to the fetus and mother.Arch Intern Med. 1989; 149: 2233-2236
- Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies.BJOG. 2001; 108: 1134-1140
- Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.N Engl J Med. 2000; 343: 1439-1444
- Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition).Chest. 2008; 133: 844S-886S
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
